News

TECH Q2 Deep Dive: Margin Pressures and Portfolio Shifts Amid Market Uncertainty
Life sciences company Bio-Techne (NASDAQ:TECH) announced better-than-expected revenue in Q2 CY2025, with sales up 3.5% year ...